First Time Loading...

CSL Ltd
ASX:CSL

Watchlist Manager
CSL Ltd Logo
CSL Ltd
ASX:CSL
Watchlist
Price: 273.3 AUD -1.85% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one CSL stock under the Base Case scenario is 325.45 AUD. Compared to the current market price of 273.3 AUD, CSL Ltd is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CSL Relative Value
Base Case
325.45 AUD
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.1
P/S
P/S
Price to Sales
6.1
vs History
95
vs Industry
60
Median 3Y
8.4
Median 5Y
8.8
Industry
8.1
Forward
5.8
More Details
34.9
P/E
P/E
Price to Earnings
34.9
vs History
87
vs Industry
5
Median 3Y
39.3
Median 5Y
39.7
Industry
26.2
Forward
29.1
More Details
32.1
P/OCF
P/OCF
Price to OCF
32.1
vs History
74
vs Industry
5
Median 3Y
33.1
Median 5Y
34.9
Industry
22.6
More Details
176.2
P/FCFE
P/FCFE
Price to FCFE
176.2
vs History
15
vs Industry
1
Median 3Y
38.6
Median 5Y
74.4
Industry
21.3
More Details
5
P/B
P/B
Price to Book Value
5
vs History
95
vs Industry
18
Median 3Y
6.3
Median 5Y
11.3
Industry
2.5
More Details
6.8
EV/S
EV/S
Enterprise Value to Sales
6.8
vs History
95
vs Industry
47
Median 3Y
8.7
Median 5Y
8.8
Industry
7.3
Forward
6.5
More Details
13.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.1
vs History
95
vs Industry
34
Median 3Y
15.8
Median 5Y
16.4
Industry
9.1
More Details
21.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.2
vs History
96
vs Industry
6
Median 3Y
25
Median 5Y
26.2
Industry
4.4
Forward
19.4
More Details
26.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.2
vs History
92
vs Industry
5
Median 3Y
30.2
Median 5Y
30.6
Industry
4.3
Forward
22.5
More Details
35.7
EV/OCF
EV/OCF
Enterprise Value to OCF
35.7
vs History
58
vs Industry
4
Median 3Y
34.1
Median 5Y
36.6
Industry
5.4
More Details
82.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
82.8
vs History
60
vs Industry
2
Median 3Y
81.9
Median 5Y
87.7
Industry
3.2
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
95
vs Industry
43
Median 3Y
5.3
Median 5Y
6.6
Industry
5
More Details

Multiples Across Competitors

CSL Competitors Multiples
CSL Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
CSL Ltd
ASX:CSL
132B AUD 6.1 34.9 21.2 26.2
US
Abbvie Inc
NYSE:ABBV
281.9B USD 5.2 58.5 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
144.5B USD 5.1 21.5 16.1 24.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 10.4 28.3 22.6 23.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
96.6B USD 7.4 24.4 16.1 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
81.5B USD 3 14.4 7.9 10.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
41.2B USD 6 -8.7 -9.2 -7.8
US
Biogen Inc
NASDAQ:BIIB
30.3B USD 3.1 26.1 14.2 17.6
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47
KR
Celltrion Inc
KRX:068270
36.6T KRW 16.8 68.3 41.9 57.7

See Also

Summary
CSL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CSL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CSL stock valuation using valuation multiples.
Wall Street Estimates
CSL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CSL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.